Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,723.34
(
0.36%
)
US TECH 100
24,126.00
(
0.46%
)
Dow Jones
47,084.05
(
0.29%
)
Brent Oil
100.82
(
2.56%
)
Bitcoin
74,774.81
(
-0.09%
)
News Focus
News Focus
Post# of 257252
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122792
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 141032

Friday, 05/04/2012 9:49:18 AM

Friday, May 04, 2012 9:49:18 AM

Post# of 257252
Royal DSM acquires KNSY for $38.50/sh in cash (a $360M valuation with a 33% premium):

http://www.reuters.com/article/2012/05/03/dsm-kenseynash-idUSL5E8G30V020120503

Kensey Nash's medical devices and biomaterials are used in cardiology, spinal and general surgery. Its best-known product, AngioSeal, is used by doctors to close punctures made in arteries, for example after using a catheter for angioplasty.

DSM acquired Martek Biosciences for $1.1B in late 2010 (#msg-57987049).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now